Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2529262017 | Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2532641019 | Neomycin sulfate+polymyxin b sulfate+prednisolone acetate 0.35%/10000unt/0.5%wv suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3084832018 | Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Is a | Product containing neomycin (medicinal product) | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Is a | Compound neomycin preparations | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Is a | Product containing neomycin in topical dosage form | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Is a | Product containing polymyxin B (medicinal product) | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Has active ingredient | Polymyxin B (substance) | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Has active ingredient | Topical neomycin | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Is a | Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Has active ingredient | Prednisolone acetate | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Has active ingredient | Polymyxin B sulfate (substance) | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Has active ingredient | Skin anti-infective | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Has active ingredient | Neomycin sulfate | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR